The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
verlukast results in decreased activity of ABCB11 protein verlukast inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
[verlukast affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [verlukast binds to and results in decreased activity of ABCC1 protein] inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of Daunorubicin; [verlukast results in decreased activity of ABCC1 protein] which results in increased susceptibility to Arsenic Trioxide; verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein affects the transport of Bilirubin]; verlukast inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione]; verlukast inhibits the reaction [ABCC1 protein mutant form results in increased transport of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Arsenic Trioxide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Mercuric Chloride]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to sodium arsenate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine]; verlukast inhibits the reaction [ABCC1 protein results in decreased uptake of and results in decreased susceptibility to Arsenic Trioxide]; verlukast inhibits the reaction [ABCC1 protein results in increased export of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC1 protein results in increased export of Daunorubicin]; verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein results in increased export of Methylmercury Compounds]; verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of zearalenol]; verlukast inhibits the reaction [ABCC1 protein results in increased transport of Zearalenone]; verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein]; verlukast inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] [Epinephrine co-treated with [verlukast results in decreased activity of ABCC1 protein]] results in increased abundance of Glutathione Disulfide; [verlukast results in decreased activity of ABCC1 protein] inhibits the reaction [Arsenates results in increased export of Glutathione]; [verlukast results in decreased activity of ABCC1 protein] which promotes the reaction and affects the abundance of Epinephrine metabolite; [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine
verlukast results in decreased activity of ABCC2 protein verlukast results in decreased activity of ABCC2 protein; verlukast results in decreased activity of ABCC2 protein modified form [verlukast results in decreased activity of ABCC2 protein] which results in decreased secretion of Resveratrol metabolite; ABCC2 protein affects the reaction [verlukast results in decreased secretion of Chenodeoxycholic Acid] [verlukast results in decreased activity of ABCC2 protein] which results in decreased export of Topotecan; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylhypaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of benzoylmesaconine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of hypaconitine; [verlukast results in decreased activity of ABCC2 protein] which results in decreased transport of mesaconitine; [verlukast results in decreased activity of ABCC2 protein] which results in increased uptake of Vinblastine; verlukast inhibits the reaction [[Adenosine Triphosphate co-treated with ABCC2 protein] results in increased uptake of estradiol-17 beta-glucuronide]; verlukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Paclitaxel]; verlukast inhibits the reaction [ABCC2 protein results in increased export of Saquinavir]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of Leukotriene C4]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of zearalenol]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of Zearalenone]; verlukast inhibits the reaction [Bucladesine results in increased activity of ABCC2 protein]
verlukast inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of Leukotriene C4]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of zearalenol]
verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein results in decreased susceptibility to Thioguanine]; verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC4 protein]; verlukast inhibits the reaction [Quercetin results in increased activity of ABCC4 protein] verlukast results in decreased activity of ABCC4 protein
alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [verlukast binds to and results in decreased activity of CYSLTR1 protein]; verlukast binds to and results in decreased activity of CYSLTR1 protein; verlukast inhibits the reaction [[Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; verlukast inhibits the reaction [Leukotriene D4 binds to and results in increased activity of CYSLTR1 protein]; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein] verlukast binds to and results in decreased activity of CYSLTR1 protein; verlukast inhibits the reaction [Leukotriene D4 binds to CYSLTR1 protein]
[verlukast binds to and results in decreased activity of ABCC1 protein] inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein]
verlukast inhibits the reaction [Ovalbumin results in increased expression of IL13 mRNA] verlukast inhibits the reaction [IL13 protein results in increased expression of MUC5AC protein]
verlukast inhibits the reaction [Bleomycin results in increased activity of MPO protein]; verlukast inhibits the reaction [Ovalbumin results in increased expression of MPO protein]
verlukast inhibits the reaction [Ovalbumin results in increased expression of MUC5AC mRNA]; verlukast inhibits the reaction [Ovalbumin results in increased expression of MUC5AC protein] verlukast inhibits the reaction [IL13 protein results in increased expression of MUC5AC protein]; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC mRNA]; verlukast inhibits the reaction [Leukotriene D4 results in increased expression of MUC5AC protein]
browse the term
